Literature DB >> 7580840

HIV-1 gp120/160 expressing cells upregulate HIV-1 LTR directed gene expression in a cell line transfected with HIV-1 LTR-reporter gene constructs.

A Merzouki1, P Patel, S Cassol, M Ennaji, P Tailor, F R Turcotte, M O'Shaughnessy, M Arella.   

Abstract

The results described in this paper demonstrate that HIV-1 gp120 can upregulate gene expression directed by the HIV-1 LTR. Briefly, exposing responder CD4+CEM-T4 ID5 cells to stimulator CEMgp120/160 expressing cells (stably transfected with HIV-1 LTR-CAT and HIV-1 gp160, respectively) resulted in the increased synthesis of the CAT enzyme. Control non-transfected CEM-T4 cells did not induce the synthesis of CAT. In addition, when the responder cell line, U937-1C5 which also contains stably transfected HIV-1 LTR-CAT plasmid was exposed to irradiated CEM gp120/160 cells, there was no synthesis of the CAT enzyme. Neither recombinant gp120 nor gp160 were able to stimulate the synthesis of CAT in the responder cells. These results indicate that the mechanism by which gp120/160 expressed on transfected cells increase CAT synthesis in responder cells may be dependent on the manner which the protein is presented in association with accessory molecules. Moreover, recombinant soluble CD4 and anti-CD4 monoclonal antibodies inhibited CEM gp120/160 induced expression of HIV-1 LTR-directed expression in CEM-1D5 cells. Based on these results we hypothesize that HIV or its envelope protein, gp120, upon interaction with its receptor, the CD4 molecule on T helper cells, transduces a signal which translates into the upregulation of the gene expression directed by the HIV-1 LTR.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7580840

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.770


  9 in total

1.  Measurement of human immunodeficiency virus type 1 preintegration transcription by using Rev-dependent Rev-CEM cells reveals a sizable transcribing DNA population comparable to that from proviral templates.

Authors:  Subashini R Iyer; Dongyang Yu; Angélique Biancotto; Leonid B Margolis; Yuntao Wu
Journal:  J Virol       Date:  2009-06-24       Impact factor: 5.103

2.  Delayed human immunodeficiency virus type 1-induced apoptosis in cells expressing truncated forms of CD4.

Authors:  C Guillerm; N Coudronnière; V Robert-Hebmann; C Devaux
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

3.  A new reporter cell line to monitor HIV infection and drug susceptibility in vitro.

Authors:  A Gervaix; D West; L M Leoni; D D Richman; F Wong-Staal; J Corbeil
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

4.  Tat controls transcriptional persistence of unintegrated HIV genome in primary human macrophages.

Authors:  Beatrix Meltzer; Deemah Dabbagh; Jia Guo; Fatah Kashanchi; Mudit Tyagi; Yuntao Wu
Journal:  Virology       Date:  2018-03-15       Impact factor: 3.616

5.  The protein tyrosine kinase p56lck is required for triggering NF-kappaB activation upon interaction of human immunodeficiency virus type 1 envelope glycoprotein gp120 with cell surface CD4.

Authors:  L Briant; V Robert-Hebmann; C Acquaviva; A Pelchen-Matthews; M Marsh; C Devaux
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

6.  Novel reporter T-cell line highly susceptible to both CCR5- and CXCR4-using human immunodeficiency virus type 1 and its application to drug susceptibility tests.

Authors:  Hiroshi Miyake; Yuji Iizawa; Masanori Baba
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

7.  Specific marking of HIV-1 positive cells using a Rev-dependent lentiviral vector expressing the green fluorescent protein.

Authors:  Jia Guo; Clinton Enos; Yuntao Wu
Journal:  J Vis Exp       Date:  2010-09-23       Impact factor: 1.355

8.  Discovery of Novel Small-Molecule Inhibitors of LIM Domain Kinase for Inhibiting HIV-1.

Authors:  Fei Yi; Jia Guo; Deemah Dabbagh; Mark Spear; Sijia He; Kylene Kehn-Hall; Jacque Fontenot; Yan Yin; Mathieu Bibian; Chul Min Park; Ke Zheng; Ha Jeung Park; Veronica Soloveva; Dima Gharaibeh; Cary Retterer; Rouzbeh Zamani; Margaret L Pitt; John Naughton; Yongjun Jiang; Hong Shang; Ramin M Hakami; Binhua Ling; John A T Young; Sina Bavari; Xuehua Xu; Yangbo Feng; Yuntao Wu
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

9.  A Subset of CD4/CD8 Double-Negative T Cells Expresses HIV Proteins in Patients on Antiretroviral Therapy.

Authors:  Laura K DeMaster; Xiaohe Liu; D Jake VanBelzen; Benjamin Trinité; Lingjie Zheng; Luis M Agosto; Stephen A Migueles; Mark Connors; Lidia Sambucetti; David N Levy; Alexander O Pasternak; Una O'Doherty
Journal:  J Virol       Date:  2015-11-04       Impact factor: 5.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.